top of page

Oncology Valuations: Acquisition of The Oklahoma Proton Center

The Oklahoma Proton Center is being purchased for $62m by a newly formed non-profit organization in a transaction exclusively financed with over ~$72m of municipal bond debt (includes additional funds for debt service reserves and issuance costs). TOPC, which was built for approximately $120m in 2009 and financed with over $100m in debt obligations, has recently undergone a startling turnaround since being purchased out of bankruptcy in late 2018.

According to bankruptcy court filings, the center was purchased by a for-profit entity affiliated with former executives of certain Provision CARES proton therapy centers for a cash purchase price of $17.25m (later adjusted to $17.75m). Fiscal year 2019 financial statements included in the municipal bond prospectus indicate that the purchase was likely financed in part with debt (~$12.3m on the balance sheet as of 12/31/2019).

The prospectus and supplemental documents also outline the swift turnaround at the center from revenue and EBITDA of $11.3m and -($4.7m) in FY 2018, respectively, to pro forma estimates of $26.4m and $6.9m in 2021. If you're interested in more context, have a look at the municipal bond prospectus.

If you have questions or would like assistance related to proton therapy valuation issues, please contact Darcy Devine at

Featured Posts
Recent Posts
Search By Tags
bottom of page